UBS, acting through its London branch, successfully completed its issuance of (i) CHF 310 million aggregate principal amount of 2.385 per cent. Notes due 2025, and (ii) CHF 150 million aggregate principal amount of 2.550 per cent. Notes due 2029, in each case under its Euro Note Programme. Homburger advised UBS with respect to all […]
AMAG Leasing issued CHF 170 million Green Bonds with a maturity date in 2026 and a coupon of 2.625%. The Green Bonds will be listed at the SIX Swiss Exchange. Zürcher Kantonalbank and UBS Investment Bank acted
MLL Legal acted as transaction counsel for the owners of Novasina and SIC Group on the sale of Novasina. Novasina specializes in the development and manufacturing of precision measuring instruments for water activity, air and
VectivBio Holding, a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare gastrointestinal conditions, and Ironwood Pharmaceuticals, a GI-focused healthcare company, announced that they had entered into an agreement for Ironwood to launch an
Meyer Burger Technology has successfully issued green senior unsecured guaranteed convertible bonds due 2029 in the aggregate amount of EUR 216.3 m. The bonds were placed in a private placement with a coupon of 3.75% per annum. The
Helveteq, a Swiss issuer of ESG-transparent investment products, is launching a pioneering and unique solution for ecological and sustainable investments in gold. The company has issued and listed a new exchange traded product (ETP) on
Orascom Development Holding announced rights offering to finance current development projects. Following this, Niederer Kraft Frey advised Swiss Finance & Property as sole lead manager and Helvetische Bank as settlement agent in this Orascom’s
Orascom Development Holding successfully completed a capital increase in the amount of CHF 135 million. The transaction consisted of
Niederer Kraft Frey advised the underwriting syndicate led by Huatai Financial Holdings on the offering of global depositary receipts (GDRs) and SIX Swiss Exchange listing of Zheijang Supcon Technology under the China-Switzerland Stock Connect. Including
Walder Wyss advises Swiss biotech Alentis Therapeutics in connection with their USD 105m Series C funding to support the development of its lead assets. The funding round was led by Jeito Capital together with Novo
